{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:07:23Z","timestamp":1795194443471,"version":"4.10.3"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"name":"Fondo de Investigaciones Sanitarias","award":["080103\/1201009"],"award-info":[{"award-number":["080103\/1201009"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective. To reach a European consensus on the definition and characterization of the main organ-specific extraglandular manifestations in primary SS.<\/jats:p>\n                  <jats:p>Methods. The EULAR-SS Task Force Group steering committee agreed to approach SS-related systemic involvement according to the EULAR SS Disease Activity Index (ESSDAI) classification and proposed the preparation of four separate manuscripts: articular, cutaneous, pulmonary and renal ESSDAI involvement; muscular, peripheral nervous system, CNS and haematological ESSDAI involvement; organs not included in the ESSDAI classification; and lymphoproliferative disease. Currently available evidence was obtained by a systematic literature review focused on SS-related systemic features.<\/jats:p>\n                  <jats:p>Results. The following information was summarized for articular, cutaneous, pulmonary and renal involvement: a clear, consensual definition of the clinical feature, a brief epidemiological description including an estimate of the prevalence reported in the main clinical series and a brief list of the key clinical and diagnostic features that could help physicians clearly identify these features. Unfortunately we found that the body of evidence relied predominantly on information retrieved from individual cases, and the scientific information provided was heterogeneous. The analysis of types of involvement was biased due to the unbalanced reporting of severe cases over non-severe cases, although the main sources of bias were the heterogeneous definitions of organ involvement (or even the lack of definition in some studies) and the heterogeneous diagnostic approach used in studies to investigate involvment of each organ.<\/jats:p>\n                  <jats:p>Conclusion. The proposals included in this article are a first step to developing an optimal diagnostic approach to systemic involvement in primary SS and may pave the way for further development of evidence-based diagnostic and therapeutic guidelines.<\/jats:p>","DOI":"10.1093\/rheumatology\/kev200","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T20:29:45Z","timestamp":1438374585000},"page":"2230-2238","source":"Crossref","is-referenced-by-count":277,"title":["Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements"],"prefix":"10.1093","volume":"54","author":[{"given":"Manuel","family":"Ramos-Casals","sequence":"first","affiliation":[{"name":"Sj\u00f6gren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, Hospital Cl\u00ednic, Barcelona, Spain,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"additional","affiliation":[{"name":"Sj\u00f6gren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, Hospital Cl\u00ednic, Barcelona, Spain,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pitaux Universitaires Paris-Sud, Assistance Publique-Hopitaux de Paris, Le Kremlin Bic\u00eatre,"},{"name":"Universit\u00e9 Paris-Sud 11, UMR 1184, Le Kremlin Bic\u00eatre, Paris, France,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Bowman","sequence":"additional","affiliation":[{"name":"Rheumatology Department, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u00f6rner","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Charit\u00e9, University Hospital, Berlin, Germany,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, EA 4438, Strasbourg University Hospital, Universit\u00e9 de Strasbourg, Strasbourg, France,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pitaux Universitaires Paris-Sud, Assistance Publique-Hopitaux de Paris, Le Kremlin Bic\u00eatre,"},{"name":"Universit\u00e9 Paris-Sud 11, UMR 1184, Le Kremlin Bic\u00eatre, Paris, France,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Skane University Hospital Malm\u00f6, Lund University, Sweden,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bombardieri","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[{"name":"Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mandl","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Skane University Hospital Malm\u00f6, Lund University, Sweden,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Fai","family":"Ng","sequence":"additional","affiliation":[{"name":"Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aike","family":"Kruize","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tzioufas","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, University of Athens, Greece and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Vitali","sequence":"additional","affiliation":[{"name":"Instituto San Giuseppe, Como and Casa di Cura di Lecco, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EULAR Sj\u00f6gren Syndrome Task Force","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"2019120510004474900_kev200-B1","doi-asserted-by":"crossref","first-page":"e3821","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ"},{"key":"2019120510004474900_kev200-B2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sj\u00f6gren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"2019120510004474900_kev200-B3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sj\u00f6gren\u2019s syndrome: new clinical and therapeutic concepts","volume":"64","author":"Ramos-Casals","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2019120510004474900_kev200-B4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","article-title":"Validation of EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","volume":"74","author":"Seror","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2019120510004474900_kev200-B5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019120510004474900_kev200-B6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2013.12.010","article-title":"Outcome measures for primary Sj\u00f6gren\u2019s syndrome: a comprehensive review","volume":"51","author":"Seror","year":"2014","journal-title":"J Autoimmun"},{"key":"2019120510004474900_kev200-B7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2006.08.007","article-title":"The overlap of Sj\u00f6gren\u2019s syndrome with other systemic autoimmune diseases","volume":"36","author":"Ramos-Casals","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"2019120510004474900_kev200-B8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0961203313515764","article-title":"Annular erythema in primary Sjogren\u2019s syndrome: description of 43 non-Asian cases","volume":"23","author":"Brito-Zer\u00f3n","year":"2014","journal-title":"Lupus"},{"key":"2019120510004474900_kev200-B9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/s10165-009-0257-y","article-title":"Annular erythema associated with Sj\u00f6gren\u2019s syndrome: review of the literature on the management and clinical analysis of skin lesions","volume":"20","author":"Katayama","year":"2010","journal-title":"Mod Rheumatol"},{"key":"2019120510004474900_kev200-B10","first-page":"647","article-title":"Bronchiectasis in primary Sj\u00f6gren\u2019s syndrome: prevalence and clinical significance","volume":"28","author":"Soto-Cardenas","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2019120510004474900_kev200-B11","doi-asserted-by":"crossref","first-page":"e73774","DOI":"10.1371\/journal.pone.0073774","article-title":"Prognostic factors in interstitial lung disease associated with primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 33 pathologically-proven cases","volume":"8","author":"Enomoto","year":"2013","journal-title":"PLoS One"},{"key":"2019120510004474900_kev200-B12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1742-1241.2009.02311.x","article-title":"Clinical approach to renal tubular acidosis in adult patients","volume":"65","author":"Reddy","year":"2011","journal-title":"Int J Clin Pract"},{"key":"2019120510004474900_kev200-B13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2215\/CJN.00980209","article-title":"Renal involvement in primary Sj\u00f6gren\u2019s syndrome: a clinicopathologic study","volume":"4","author":"Maripuri","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019120510004474900_kev200-B14","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.38100","article-title":"Clinically significant renal involvement in primary Sj\u00f6gren\u2019s syndrome: clinical presentation and outcome","volume":"65","author":"Goules","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2019120510004474900_kev200-B15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaad.2007.05.023","article-title":"Amicrobial pustulosis associated with IgA nephropathy and Sj\u00f6gren\u2019s syndrome","volume":"57","author":"Natsuga","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2019120510004474900_kev200-B16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2230.2011.04262.x","article-title":"Amicrobial pustulosis associated with autoimmune disease in a patient with Sj\u00f6gren syndrome and IgA nephropathy","volume":"37","author":"Lim","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"2019120510004474900_kev200-B17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology"},{"key":"2019120510004474900_kev200-B18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/acr.21991","article-title":"European League Against Rheumatism Sj\u00f6gren\u2019s Syndrome Disease Activity Index and European League Against Rheumatism Sj\u00f6gren\u2019s Syndrome Patient-Reported Index: a complete picture of primary Sj\u00f6gren\u2019s syndrome patients","volume":"65","author":"Seror","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2019120510004474900_kev200-B19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology"},{"key":"2019120510004474900_kev200-B20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/annrheumdis-2012-202779","article-title":"EULAR definition of erosive disease in light of the 2010 ACR\/EULAR rheumatoid arthritis classification criteria","volume":"72","author":"van der Heijde","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2019120510004474900_kev200-B21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","article-title":"Cutaneous vasculitis in primary Sj\u00f6gren syndrome: classification and clinical significance of 52 patients","volume":"83","author":"Ramos-Casals","year":"2004","journal-title":"Medicine"},{"key":"2019120510004474900_kev200-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2019120510004474900_kev200-B23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/clc.4960290909","article-title":"The value of using the entire New York Heart Association\u2019s classification of heart and vascular disease","volume":"29","author":"Hurst","year":"2006","journal-title":"Clin Cardiol"},{"key":"2019120510004474900_kev200-B24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2019120510004474900_kev200-B25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(05)66583-X","article-title":"Glomerulonephritis","volume":"365","author":"Chadban","year":"2005","journal-title":"Lancet"},{"key":"2019120510004474900_kev200-B26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"2019120510004474900_kev200-B27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/54\/12\/2230\/31223779\/kev200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/54\/12\/2230\/31223779\/kev200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T10:00:59Z","timestamp":1575540059000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/54\/12\/2230\/1792983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,7,31]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kev200","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,12]]},"published":{"date-parts":[[2015,7,31]]}}}